发明名称 |
Cyclin dependent kinase inhibitor |
摘要 |
The present invention is based on the method of treating a patient suffering from leukemia comprising administering a therapeutically effective amount of the compound 2-([(3-hydroxypropyl)amino]-6-benzylamino)-9-isopropylpurine or a pharmaceutically acceptable salt thereof.
|
申请公布号 |
US6221873(B1) |
申请公布日期 |
2001.04.24 |
申请号 |
US19980034581 |
申请日期 |
1998.03.04 |
申请人 |
INSTITUTE OF EXPERIMENTAL BOTANY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC |
发明人 |
HAVLICEK LIBOR;STRNAD MIROSLAV;HAJDUCH MARIAN |
分类号 |
C07D473/16;A61K31/52;A61P35/00;A61P35/02;A61P43/00;(IPC1-7):A61K31/52 |
主分类号 |
C07D473/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|